Society of Nuclear Medicine and Molecular Imaging

What Society of Nuclear Medicine and Molecular Imaging does

Founded in 1954 and headquartered in Reston, Virginia, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international 501(c)(3) nonprofit scientific and medical organization supporting the fields of nuclear medicine, molecular imaging, and theranostics. It serves physicians, technologists, researchers, and—through a Patient Education Day—patients and caregivers, with approximately 45 paid staff operating alongside an extensive volunteer leadership structure that includes a Board of Directors, House of Delegates, and a dedicated technologist section (SNMMI-TS).

Name

Society of Nuclear Medicine and Molecular Imaging

Legal name

Society for Nuclear Medicine and Molecular Imaging

Website

https://snmmi.org

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

11–50 employees

Short description

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international 501(c)(3) nonprofit professional society serving nuclear medicine physicians, technologists, and scientists worldwide through peer-reviewed journals, clinical trial networks, registries, accreditation programs, and a flagship annual meeting.

Ownership category

akta.pro rank

Headquarters

HQ city

Reston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Dues: Annual membership fees providing access to publications, educational resources, networking communities, and professional development opportunities.
2. Journal Subscriptions: Subscription revenue from The Journal of Nuclear Medicine and Journal of Nuclear Medicine Technology, including institutional and individual subscriptions.
3. Annual Meeting Registration: Registration fees for the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging, attracting over 8,000 registrants.
4. Advertising & Sponsorships: Marketing and communication opportunities delivering messages to key decision makers from the international nuclear medicine and molecular imaging community, including exhibitor booths and sponsorships.
5. Book Sales & Publications: Sale of books, pharmacology guides, and other educational materials including the 'Pharmacology in Nuclear Medicine and Medical Imaging' guide.
6. Mailing List Rental: Rental of membership and annual meeting attendee mailing lists to reputable organizations.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

SNMMI is a nonprofit professional membership organization that advances nuclear medicine, molecular imaging, and radiopharmaceutical therapy through peer-reviewed scientific journals (JNM and JNMT), an annual scientific meeting, a Clinical Trials Network with standardized phantoms, the RaPTR patient outcomes registry, accreditation programs for radiopharmaceutical therapy centers, and continuing education for physicians, scientists, and technologists worldwide.

Product overview

SNMMI is a professional organization offering a portfolio of publications, research networks, registries, and educational programs for nuclear medicine and molecular imaging professionals. The core products include two peer-reviewed journals (The Journal of Nuclear Medicine and Journal of Nuclear Medicine Technology), the Clinical Trials Network with imaging standardization tools (phantoms, PAT, DREAM database), and the Radiopharmaceutical Therapy Registry (RaPTR) for tracking patient outcomes. Research initiatives include the Mars Shot Fund for cancer imaging research and the Fellows Program. SNMMI also provides accreditation for Radiopharmaceutical Therapy Centers of Excellence, operates the Annual Meeting as a premier industry event, and publishes the SmartBrief newsletter for ongoing education.

Differentiator

Problem solved

Functional benefit

Products and services

• Journal of Nuclear Medicine (JNM) Monthly peer-reviewed scientific journal publishing original research, reviews, and editorials in nuclear medicine, molecular imaging, and theranostics for physicians, scientists, and technologists.
• Journal of Nuclear Medicine Technology (JNMT) Quarterly peer-reviewed journal covering technology, instrumentation, and clinical practice topics for nuclear medicine technologists.
• SNMMI Clinical Trials Network (CTN) Multi-center research network providing standardized imaging protocols, phantom scans, and centralized analysis to enable reproducible multi-site clinical trials in oncology, neurology, and cardiology imaging for investigators, sponsors, and academic centers.
• RaPTR (Radiopharmaceutical Therapy Registry) Outcomes registry capturing de-identified clinical data from patients receiving radiopharmaceutical therapies across participating sites, enabling real-world evidence generation for clinicians, treatment centers, and therapy sponsors.
• SNMMI Annual Meeting Annual scientific meeting delivered in-person and virtually featuring scientific sessions, continuing education courses, industry exhibits, and networking for physicians, scientists, technologists, and industry partners in nuclear medicine and molecular imaging.
• Radiopharmaceutical Therapy Center of Excellence Accreditation Site accreditation program evaluating healthcare facilities against SNMMI-defined standards for radiopharmaceutical therapy, recognizing centers that meet quality, safety, and practice criteria for theranostics service delivery.
• SNMMI Membership Tiered individual professional membership providing access to JNM and JNMT subscriptions, member communities, practice guidelines, advocacy resources, and member pricing for meetings and education for physicians, scientists, technologists, pharmacists, and trainees in nuclear medicine.
• Pharmacology in Nuclear Medicine and Medical Imaging Textbook reference covering radiopharmaceutical pharmacology for nuclear medicine physicians, scientists, and technologists seeking foundational and advanced knowledge of imaging agents.

Quantifiable outcome

• Radiopharmaceutical Therapy Center of Excellence accreditation recognizes centers meeting rigorous standards in patient care, training, and expertise in theranostics
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

13 partnerships are on record, tiered core and supporting.

• Malaysian Society of Nuclear Medicine and Molecular Imaging (MSNMMI)coreStrategic or Co-development Partner · 24 February 2026Launched MyNuCLEaR, a nationwide integrated platform for nuclear medicine care, education and resources in Malaysia, in collaboration with the Ministry of Health and with industry support from Novartis Malaysia. The platform provides a searchable directory of accredited nuclear medicine facilities, strengthens referral pathways, and offers professional development resources.
• Novartis MalaysiasupportingStrategic or Co-development PartnerIndustry partner supporting the MyNuCLEaR platform for improving patient access to advanced theranostics therapies such as for prostate cancer, enabling earlier detection and more targeted treatment across Malaysia.
• Blue Earth DiagnosticssupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026
• CuriumsupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026; provides Detectnet product for neuroendocrine tumor detection
• ITM Isotope Technologies Munich SEsupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026; developing Raytherity for radiopharmaceutical therapy
• LantheussupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026; provides PSMA scanning support and understanding of neuroendocrine tumors
• Mirion MedicalsupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026
• NovartissupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026; provides PSMA testing resources through scanforpsma.com
• Telix PharmaceuticalssupportingGTM or Marketing PartnerSponsor of SNMMI Patient Education Day 2026
• Curanosticum Wiesbaden-Frankfurt / ICPO Center of ExcellencecoreStrategic or Co-development PartnerResearch partner leading FAP-targeted radiopharmaceutical therapy first-in-human study published in Journal of Nuclear Medicine; key opinion leader site for theranostics research
• Nuclear Medicine Clinical Trial Group, LLC (NMCTG)coreStrategic or Co-development PartnerAssists with radiopharmaceutical imaging or therapy clinical trials from trial design, site selection, imaging equipment validation; partnered with dozens of sponsors and CROs to set up clinical trials for success
• Results DirectsupportingTechnology or IntegrationWebsite hosting services provider located at 101 N Columbus St, Suite 300, Alexandria, VA 22314 USA
• Microsoft AzuresupportingTechnology or IntegrationData hosting services provider located at One Microsoft Way, Redmond, WA 98052; stores SNMMI's data

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Radiological Society of North America (RSNA): The dominant radiology professional society in North America, operating the largest radiology annual meeting (RSNA Scientific Assembly), publishing Radiology, and running research and education programs — the closest comparable in scale and mission to SNMMI, but in a broader imaging specialty.
• American College of Radiology (ACR): National medical specialty society for radiologists, offering accreditation (including nuclear medicine/PET accreditation), practice standards, and annual meetings — directly comparable as a society-driven standards and accreditation body that overlaps SNMMI's accreditation franchise.
• European Association of Nuclear Medicine (EANM): The principal European counterpart to SNMMI, running the annual EANM Congress and publishing the European Journal of Nuclear Medicine and Molecular Imaging — a near-perfect functional peer with overlapping scientific, educational, and society membership offerings.

Broad incumbents

• American College of Cardiology (ACC): Cardiology specialty society running a major annual meeting (ACC.25/26), JACC journals, and certification/accreditation programs. Directly comparable to SNMMI in structure (nuclear cardiology is a sub-area), with nuclear cardiology imaging being a meaningful overlap.
• American Society of Clinical Oncology (ASCO): Large, well-capitalized oncology professional society running the ASCO Annual Meeting (>40,000 attendees) and the Journal of Clinical Oncology. Comparable in nonprofit professional society model and journal + meeting flywheel, though SNMMI is much smaller and more specialized.

Regional players

• World Federation of Nuclear Medicine and Biology (WFNMB): Global umbrella society for nuclear medicine covering regions where SNMMI does not directly compete (Asia, Latin America, Africa). Functionally peer-equivalent as a professional society, with overlapping membership and conference activity.

Emerging players

• Society for Imaging Informatics in Medicine (SIIM): Imaging-informatics society focused on AI, PACS, and data in radiology — adjacent to SNMMI's CTN/PAT imaging standardization work and a potential partner or substitute for informatics-facing educational content.
• American Association of Physicists in Medicine (AAPM): Medical physics professional society running an annual meeting and Scientific Journal — overlaps with SNMMI's audience (physics/PET-SPECT personnel) and shares the nonprofit society + journal + meeting model.

Others

• American Roentgen Ray Society (ARRS): Long-standing radiology professional society publishing the American Journal of Roentgenology and running the ARRS Annual Meeting — a direct structural peer in society + journal + meeting model, addressing an overlapping imaging audience.
• International Society for Pharmaceutical Engineering (ISPE): Nonprofit society for pharma engineering/manufacturing that runs large conferences, training, and publications — comparable in nonprofit society operating model and meeting/journal revenue mix, though serving a different audience.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/snm_mi
• YouTubeyoutube.com/SNMChannel1
• Facebookfacebook.com/society-of-nuclear-medicine-and-molecular-imaging-55278318943
• LinkedInlinkedin.com/company/society-of-nuclear-medicine-and-molecular-imaging
• Instagraminstagram.com/snm_mi

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society of Nuclear Medicine and Molecular Imaging